NEIMETH INTERNATIONAL PHARMACEUTICALS AUDITED ACCOUNTS FOR THE PERIOD ENDED SEPTEMBER 2014
Revenue (Millions)
2014 N1628.3
2013 N2016.5
%age Change (-19%)
Profit/(Loss) after tax
2014 -N228.5
2013 N151.5
%age Change (-251%)
Earnings/(Loss) Per Share
2014 -15 Kobo
2013 10 Kobo
%age (-251%)
